Related Experiment Video

Updated: Aug 6, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Endocrine Heart Disease

Deepak R. Talreja1, Gregory W. Barsness

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. barsness.gregory@mayo.edu

Current Treatment Options in Cardiovascular Medicine
|February 23, 2002
PubMed

Insights

Diabetes and thyroid disease significantly worsen cardiovascular outcomes, necessitating integrated endocrine and cardiac care. Proper management requires addressing metabolic disturbances and screening for thyroid dysfunction in heart patients.

Area of Science:

  • Endocrinology and Cardiology
  • Metabolic disorders and cardiovascular health

Background:

  • Rising rates of obesity and diabetes mellitus contribute to a cardiovascular disease epidemic.
  • Diabetic patients exhibit poorer prognoses for chronic coronary artery disease and acute coronary syndromes.
  • Thyroid disease is a common endocrine disorder impacting cardiovascular patient function.

Purpose of the Study:

  • To highlight the critical intersection of endocrine and cardiovascular diseases.
  • To emphasize the need for integrated management strategies for patients with both conditions.
  • To underscore the importance of recognizing endocrine disorders presenting with cardiovascular manifestations.

Main Methods:

  • Review of existing literature on diabetes, thyroid disease, and cardiovascular outcomes.
  • Analysis of therapeutic strategies for cardiovascular disease in diabetic versus non-diabetic patients.
  • Discussion of diagnostic approaches, including thyroid-stimulating hormone screening for cardiac patients.

Main Results:

  • Diabetes is associated with significantly worse cardiovascular prognosis.
  • Management of cardiovascular disease in diabetics must address metabolic disturbances.
  • Screening for thyroid dysfunction is recommended for patients with coronary artery disease or arrhythmias.

Conclusions:

  • Integrated understanding of endocrine and cardiac systems is crucial for optimal patient care.
  • Endocrine disorders frequently present with cardiovascular symptoms, requiring careful evaluation.
  • Tailored management considering metabolic and endocrine status improves cardiovascular outcomes.

More Related Videos

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...